International differences in employee silence motives: Scale validation, prevalence, and relationships with culture characteristics across 33 countriesMichael Knoll, Rolf van Dick, Kenta Hino et al.|Journal of Organizational Behavior|2021Cited by 97
MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemiaMaría Luz Morales, Joaquín Martínez‐López, Alicia Arenas et al.|Scientific Reports|2019Cited by 32
Inhibition of related<scp>JAK</scp>/<scp>STAT</scp>pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasmSantiago Barrio, Joaquín Martínez‐López, Miguel Gallardo et al.|British Journal of Haematology|2013Cited by 24
Proteomic analysis reveals heat shock protein 70 has a key role in polycythemia VeraMiguel Gallardo, Joaquín Martínez‐López, Santiago Barrio et al.|Molecular Cancer|2013Cited by 21
PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phaseJuan Manuel Alonso‐Domínguez, Joaquín Martínez‐López, Luis Felipe Casado et al.|PLoS ONE|2017Cited by 10